Disease burden of stroke from 1990 to 2017 in Hunan Province

LIU Yuan; XU Qiao-hua; YIN Lei; JIN Dong-hui

doi:10.16462/j.cnki.zhjbkz.2021.01.019

Volume 25 Issue 1

Jan. 2021

Turn off MathJax

Article Contents

Article Navigation > CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION > 2021 > 25(1): 101-107

LIU Yuan, XU Qiao-hua, YIN Lei, JIN Dong-hui. Disease burden of stroke from 1990 to 2017 in Hunan Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(1): 101-107. doi: 10.16462/j.cnki.zhjbkz.2021.01.019

Citation:

LIU Yuan, XU Qiao-hua, YIN Lei, JIN Dong-hui. Disease burden of stroke from 1990 to 2017 in Hunan Province[J]. CHINESE JOURNAL OF DISEASE CONTROL & PREVENTION, 2021, 25(1): 101-107. doi: 10.16462/j.cnki.zhjbkz.2021.01.019

Citation:

PDF( 23579 KB)

Disease burden of stroke from 1990 to 2017 in Hunan Province

doi: 10.16462/j.cnki.zhjbkz.2021.01.019

Department of Non-communicable Disease Control and Prevention, Hunan Center for Disease Control and Prevention, Changsha 410005, China

Funds:

Hunan Health Committee in 2020 20201255

More Information

Corresponding author: JIN Dong-hui, E-mail:942019814@qq.com
Received Date: 2020-03-19
Rev Recd Date: 2020-09-13
Publish Date: 2021-01-10

Abstract

Abstract

Objective The objective of this study is to investigate the disease burden of stroke in Hunan Province, which may help to guide priority in control and prevention of stroke. Methods Data were extracted from Global Burden of Diseases Study 2017 (GBD 2017). Mortality, years of life lost (YLLs), years lived with disability (YLDs), disability adjusted life years (DALYs) associated with stroke, together with the age-standardized rates and change of the indexes mentioned above between 1990 and 2017 in Hunan were selected and described. Results From 1990-2017, death number of stroke in Hunan witnessed an increase of 85.84% (1990 vs 2017: 76 900 vs 114 300), and death number of male increased by 122.56%, while that of females increased only by 2.12%. Age-standardized mortality rate of stroke decreased by 37.58% (1990 vs 2017: 218.55/100 000 vs 136.41/100 000). Males' age-standardized mortality of stroke decreased only by 4.16%, while that of female decreased sharply by 58.18%. YLLs of stoke increased by 84.79% (1990 vs 2017: 1 637 400 vs 2 035 700 person years); Males' YLLs of stroke increased largely by 94.94%, while that of females decreased by 22.62%. Age-standardized rate of YLL of stoke decreased by 41.67% (1990 vs 2017: 3 742.85/100 000 vs 2 183.06/100 000), while females' age-standardized rate of YLL decreased by 64.45%, ahead of that of male's 6.62%. YLDs of stroke increased by 171.63% (1990 vs 2017: 113 500 vs 308 300 person years). Males' YLDs of stroke increased by 197.58%, and that of females also increased by 151.72%. Age-standardized rate of YLD also witnessed an increase of 41.74%(1990 vs 2017: 235.13/100 000 vs 333.28 /100 000); Males' age-standardized rate of YLD increased by 58.89%, while that of females increased by 28.22%. DALYs increased by 33.88% (1990 vs 2017: 1 750 900 vs 2 344 100 person years), while age-standardized rate of DALY decreased by 36.74% (1990 vs 2017: 3 977.98/100 000 vs 2 516.34/100 000). Hemorrhagic stroke contributed the most part for DALYs among different kinds of stroke, while DALYs of ischemic stroke increased rapidest by 142.64%. Conclusions Disease burden of stroke from 1990-2017 in Hunan witnessed an increase, with an obvious gender difference. Hemorrhagic stroke contributed the most part for disease burden compared with other strokes, while ischemic stroke increased most rapidly.
- Cardiovascular diseases,
- Stroke,
- Disease burden,
- Global burden of diseases study

FullText(HTML)

References(21)

References

[1]	Yang GH, Wang Y, Zeng YX, et al. Rapid health transition in China, 1990-2010: findings from the Global Burden of Disease Study 2010[J]. Lancet, 2013, 381(9882):1987-2015. DOI: 10.1016/S0140-6736(13)61097-1.
[2]	Liu SW, Li YC, Zeng XY, et al. Burden of cardiovascular diseases in China, 1990-2016: findings from the 2016 Global Burden of Disease Study[J]. JAMA Cardiol, 2019, 4(4):342-352. DOI: 10.1001/jamacardio.2019.0295.
[3]	Zhou MG, Wang HD, Zeng XY, et al. Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 394(10204):1145-1158. DOI: 10.1016/S0140-6736(19)30427-1.
[4]	Murray CJL, Lopez AD. Measuring the Global Burden of Disease[J]. N Engl J Med, 2013, 369(5):448-457. DOI: 10.1056/NEJMra1201534.
[5]	Roth GA, Abate D, Abate KH, et al. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):1736-1788. DOI: 10.1016/S0140-6736(18)32203-7.
[6]	Murray CJL, Callender CSKH, Kulikoff XR, et al. Population and fertility by age and sex for 195 countries and territories, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):1995-2051. DOI: 10.1016/S0140-6736(18)32278-5.
[7]	GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2019, 392(10159):1789-1858. DOI: 10.1016/S0140-6736(18)32279-7.
[8]	GBD 2017 DALYs and HALEs Collaborators. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):1859-1922. DOI: 10.1016/S0140-6736(18)32335-3.
[9]	Stanaway JD, Afshin A, Gakidou E, et al. Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):1923-1994. DOI: 10.1016/S0140-6736(18)32225-6.
[10]	Lozano R, Fullman N, Abate D, et al. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):2091-2138. DOI: 10.1016/S0140-6736(18)32281-5.
[11]	Collaborators GM. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017[J]. Lancet, 2018, 392(10159):1684-1735. DOI: 10.1016/s0140-6736(18)31891-9.
[12]	Murray CJL, Ezzati M, Flaxman AD, et al. GBD 2010: design, definitions, and metrics[J]. Lancet, 2012, 380(9859):2063-2066. DOI: 10.1016/S0140-6736(12)61899-6.
[13]	Salomon JA, Haagsma JA, Davis A, et al. Disability weights for the Global Burden of Disease 2013 study[J]. Lancet Global Health, 2015, 3(11):e712-e723. DOI: 10.1016/S2214-109X(15)00069-8.
[14]	刘江美, 刘韫宁, 王黎君, 等. 1990年与2010年中国心血管病疾病负担研究[J].中华预防医学杂志, 2015, 49(4):345-350. DOI: 10.3760/cma.j.issn.0253-9624.2015.04.014. Liu JM, Liu YN, Wang LJ, et al. Burden of cardiovascular disease in China in 1990 and 2010[J]. Chin J Prev Med, 2015, 49(4):345-350. DOI: 10.3760/cma.j.issn.0253-9624.2015.04.014.
[15]	Clegg D, Hevener AL, Moreau KL, et al. Sex hormones and cardiometabolic health: role of estrogen and estrogen receptors[J]. Endocrinology, 2017, 158(5):1095-1105. DOI: 10.1210/en.2016-1677.
[16]	Wang WZ, Wang D, Liu HM, et al. Trend of declining stroke mortality in China: reasons and analysis[J]. Stroke Vasc Neurol, 2017, 2(3):132-139. DOI: 10.1136/svn-2017-000098.
[17]	Tzoulaki I, Elliott P, Kontis V, et al. Worldwide exposures to cardiovascular risk factors and associated health effects: current knowledge and data gaps[J]. Circulation, 2016, 133(23):2314-2333. DOI: 10.1161/CIRCULATIONAHA.115.008718.
[18]	He YN, Li YP, Yang XG, et al. The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982-2012: a cross-sectional population-based study[J]. Lancet Diabetes Endocrinol, 2019, 7(7):540-548. DOI: 10.1016/S2213-8587(19)30152-4.
[19]	Li YC, Zeng X, Liu J, et al. Can China achieve a one-third reduction in premature mortality from non-communicable diseases by 2030?[J]. BMC Medicine, 2017, 15(1):132. DOI: 10.1186/s12916-017-0894-5.
[20]	World Health Organization. 65 th World Health Assembly. WHA65(8) Prevention and control of noncommunicable diseases: follow-up to the High-level meeting of the United Nations General Assembly on the Prevention and Control of Non- communicable diseases.[EB/OL]. (2012-05-26)[2019-03-19]. http://apps.who.int/gb/ebwha/pdf_files/WHA65/A65_DIV3-en.pdf.
[21]	Singh GM, Danaei G, Farzadfar F, et al. The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis[J]. PLoS One, 2013, 8(7):e65174. DOI: 10.1371/journal.pone.0065174.